M
LIVE

Serial Number

79225539

Owner

MAAT PHARMA

Attorney

Jeffrey H. Greger, Esq.

Filing Date

Dec 1, 2017

Add to watchlist:

No watchlists yet
View on USPTO

M Trademark

Serial Number: 79225539 • Registration: 5663397

M is a trademark filed by MAAT PHARMA on December 1, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MAAT PHARMA (12 trademarks)

70 avenue Tony Garnier

Entity Type: 99

Trademark Details

Filing Date

December 1, 2017

Registration Date

January 29, 2019

Published for Opposition

November 13, 2018

Goods & Services

[ Education, namely classes, seminars, workshops, in the field of, microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training, namely, organization and conducting of colloquiums, conferences, congresses, seminars in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; education, namely, arranging of exhibitions for educational purposes; training, namely, arranging and conducting workshops in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy ]

[ Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for others; technical project studies namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy ]

Pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; food supplements for humans and animals; dietary supplements for humans and animals, namely, nutritional supplements; dietary supplements for humans and animals, namely, dietetic food and beverages for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely, microbiotherapy preparations for the repair of intestinal microbiome; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use, namely for the treatment of gut dysbiosis related diseases; culture media for bacteriology; chemico-pharmaceutical preparations, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for the repair of intestinal microbiome

Filing History

PROOF OF USE INTERIM ACTION ISSUED
Dec 18, 2025 PUMI
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 11, 2025 EROP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 10, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 10, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 10, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 10, 2025 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 19, 2025 NREP
OFFICE ACTION ISSUED POU1
Jul 15, 2025 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 14, 2025 APRE
TEAS SECTION 71 RECEIVED
Jun 25, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 29, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 15, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 20, 2019 FICS
FINAL DISPOSITION PROCESSED
May 20, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 29, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 29, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Nov 23, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 13, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 13, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 24, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 24, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 24, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2018 TROA
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 10, 2018 FINT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 19, 2018 OPNX
REFUSAL PROCESSED BY IB
Apr 20, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 26, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 26, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2018 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 2, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2018 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 25, 2018 SDRC